# Stereotactic Body Radiotherapy for the Treatment of Solitary Bone Plasmacytoma

> **NCT03312868** · PHASE2 · TERMINATED · sponsor: **Instituto do Cancer do Estado de São Paulo** · enrollment: 10 (actual)

## Conditions studied

- Plasmacytoma

## Interventions

- **RADIATION:** SBRT

## Key facts

- **NCT ID:** NCT03312868
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-01
- **Primary completion:** 2022-03-28
- **Final completion:** 2022-03-28
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Burocracy and funding
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03312868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03312868, "Stereotactic Body Radiotherapy for the Treatment of Solitary Bone Plasmacytoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03312868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*